Technology | January 14, 2013

Bionix Radiation Therapy introduces Embrace, a Premium Thermoplastic Material Made in the USA.

Embrace Thermoplastic Bionix Radiation Therapy

January 14, 2013 — Embrace Thermoplastic is a premium low-melt material used to create customizable immobilization for patients receiving radiation therapy treatments of the head and neck. Embrace Thermoplastic products include Standard UFrames, Versaboard frames, S-Type frames, and Thermoplastic sheets. All Embrace Thermoplastic products are made in the United States. 

Embrace Thermoplastic features minimal tackiness and shrinkage, and encompasses an even hole distribution pattern after molding which helps increase overall rigidity. Embrace provides a smooth comfort edge, which ensures maximum patient comfort along the neckline. 

Embrace standard U-Frames fit most head boards industry wide, and feature more thermoplastic with a durable, narrow frame.  Embrace Versaboard Frames fit Bionix Versaboard and Max 3 Supine Breast Systems. The S-type frames, available in February, fit the S-Type System. The Thermoplastic sheets are specifically designed for intensity modulated radiation therapy treatments (IMRT). 

The product is available now for immediate purchase excluding the S-Type Frames, which will be available in February. 

For more information: www.BionixRT.com

Related Content

El Camino Hospital to Offer Calypso 4-D Localization System
News | Radiation Therapy | July 21, 2017
El Camino Hospital (Mountain View, Calif.) announced the installation of a new Calypso 4-D Localization System and will...
Eight Proton Therapy Centers Worldwide Adopt RayStation for Treatment Planning
News | Treatment Planning | July 21, 2017
RaySearch Laboratories reported that eight additional proton therapy centers worldwide have recently chosen RayStation...
Electronic Brachytherapy Comparable to Mohs Surgery in Early-Stage Non-Melanoma Skin Cancer Treatment
News | Brachytherapy Systems | July 20, 2017
July 20, 2017 — Rates of recurrence in early-stage non-melanoma skin cancer (NMSC) patients were virtually identical
ACR Updates Radiation Oncology and Medical Physics Guidance With ASTRO and AAPM
News | Radiation Dose Management | July 19, 2017
July 19, 2017 — The American College of Radiology (ACR) recently collaborated with professional medical societies to
News | Radiation Therapy | July 19, 2017
July 19, 2017 — The members of the American Society for Radiation Oncology (ASTRO) have elected three new officers to
Glendale Adventist Medical Center Opens Temporary Radiotherapy Vault
News | Radiation Therapy | July 19, 2017
July 19, 2017 — RAD Technology Medical Systems announced their most recent project at Glendale Adventist Medical Cent
IBA to Install Proton Therapy Facility at Inova Schar Cancer Institute
News | Proton Therapy | July 18, 2017
IBA (Ion Beam Applications S.A.) and Inova recently signed a contract for a two-room Proteus Plus proton therapy...
Proton International and Beaumont Health Open Michigan's First Proton Therapy Facility
News | Proton Therapy | July 17, 2017
Proton International (PI) and Beaumont Health recently opened the state’s first proton therapy center, offering the...
ASTRO Updates Insurance Coverage Recommendations for Proton Therapy
News | Proton Therapy | July 17, 2017
The American Society for Radiation Oncology (ASTRO) has issued an update to its recommendations for medical insurance...
PET/CT Tracer Identifies Vulnerable Lesions in Non-Small Cell Lung Cancer Patients

Example of a patient with an upper left lung NSCLC: A: FDG; B: FDG PET/CT; C: Planning radiotherapy based on FDG (66Gy) with BTVm (GTV), CTV and PTV; D: PET FMISO E: FMISO PET/CT; F: boost based on the FMISO PET (76Gy) with BTVh (biological hypoxic target volume) and PTV boost. Credit: QuantIF – LITIS EA 4108 – FR CNRS 3638, Henri Becquerel Cancer Center, Rouen, France

News | PET-CT | July 14, 2017
July 14, 2017 — Fluorine-18 (18F)-fluoromisonidazole (FMISO) is a positron emission tomography (PET)...
Overlay Init